Banerji Protocol Meeting
25 April 2013
In Attendance:
Dr. Iris R Bell
Khadija Ben-Aissa
Peter Gold
Dr. Pratip Banerjee
Dr. Leanna J Standish
Dr. Barbara Sarter
Not in Attendence:
Dr. Shankar Gupta
Anil Srivastava
Charles Maynard
Rubayi Srivastava
Professor, Department of Family and Community Medicine,
Research Professor, College of Nursing, University of Arizona.
Scientific Program Coordinator, Open Health Systems
Laboratory, Maryland.
expert on media and publicity for the homeopathic
community in the US
The Prasanta Banerji Homeopathic Research Foundation
Dr. Standish’s research over the last 15 years has been
focused on HIV/AIDS, cancer, hepatitis C and functional
brain-imaging cancer.
Associate Professor, Hahn School of Nursing and Health
Sciences, University of San Diego, California.
Branch, NCI, National Institute of Health, Maryland.
PhD, Program Director, Pharmaceutical Resources
(PBHRF), Kolkata.
President, Open Health Systems Laboratory, Maryland.
Executive Dir., Open Health Systems Laboratory, Maryland.
PPP Project Manager, Open Health Systems Laboratory,
California.
Topics of Discussion
Discussion:
GBM Publication:
 Pratip: Dr. Sushanta was silent till last 2 weeks.
 Pratip has been in communication with him. He has deposit one of his staff, a
post doc to work on the project in collaboration with the Banerjis and
Barbra. They asked again for the data because they lost the information
stored in their computers.
Homeopathic Remedies:
 Pratip: SBL has no point of distribution in the USA.
 The banerjis can provide directly from their clinics the remedies required for
the research part (nanoparticle/IRIS) and for the clinical trial (human trial/
Dr. Leanna) as a research material.
 Iris: remedies requirements: duplicates/ multiple samples.
 Peter: Generate a level of social attention to the benefits of the Banerji
protocol in treating Brain cancer by using the social media channels he has in
his disposal.


Barbra and Partip agreed on doing that
The Banerji book is in process of publication and Pratip will send a copy to
each member in the group.

Data mining from the clinic:
 Barbara, it was difficult to collect data. Examples: No initial stage for Breast
cancer patients and no date of initial diagnosis for GBM. The brain tumor files
did not have an adequate dataset to use for publication due to lack of followup data.
 NCI OCCAM is about to complete its fourth Best Case Series of GBM cases.
 Barbara: possible to include that in the manuscript or as a separate
manuscript.
SIO Conference:
 Patrip and Barbara: For the SIO conference it would be good to keep the
translational science group and Dr. Jeff White aware of the nanoparticle
aspect of the homeopathic remedies.
 Iris will submit an abstract for that.
 Barbara will submit an abstract discussing the benefits of conducting canine
studies to test natural products.
Action items for next meeting:
1. Welcome new members to the BP consortium, Dr. Joyce Frye (university
of Maryland) and Mrs. Alison Teitelbaum ((National Center for
Homeopathy)
2. Pratip will send a joint e-mail to Barbara and Dr. Sushanta Banerjee for an
update about the Banerji protocol and GBM manuscript.
3. Dr. Barbara will write a draft of summary paper about converting a
complicated clinical record form provided by NCI to a more friendly form
used by the clinic staff in a very busy clinical environment without losing
accuracy of the information and allowing more accurate scientific
analysis.
4. Abstracts circulation for submission to the SIO conference.
5. The group will discuss the possibility to seek funding for a POMES study
in Kolkata.
6. Anil, will suggest possible funders from India.
7. Dr. Leanna needs to send her mailing address to Khadija